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Objective. Over the last few years, a wide number of unregulated substances have been marketed on theWeb and in smart and head
shops; they are usually advertised as legal alternatives to commonly known drugs and are defined as “smart drugs,” “legal highs,”
and “novel psychoactive substances” (NPS). Aim of our work is to describe use habits and distribution of NPS in a population
of young adults in Rome club scene. Methods. A self-administered questionnaire was proposed to subjects over 18 years of age
at the entrance of 5 nightclubs in Rome. Socioeconomic characteristics and substance use were investigated. Results. Preliminary
results give evidence that 78% of respondents have a lifetime history of NPS use. In addition, 56% of the sample has consumed
illicit drugs in the past and 39% has used psychoactive substances in the 12 hours preceding the questionnaire administration.
Conclusions. A significant proportion of subjects report use of novel psychoactive substances; traditional illicit drugs consumption,
particularly cocaine, appears to be very high as well in the club scene. These data highlight a serious public health challenge,
since pharmacological, toxicological, and psychopathological effects linked to interactions among all these substances may be
unpredictable and sometimes fatal in vulnerable individuals.
1. Introduction
So-called “club drugs,” psychoactive substances associated
with club and rave cultures, proliferated in the 1990s and
remained key substances for years among youth and young
adults [1]. The U.S. National Institute on Drug Abuse
(NIDA) in its “Community Alert on Club Drugs” identified
ecstasy (3,4-methylenedioxymethamphetamine or MDMA),
Gamma-hydroxybutyrate (GHB), ketamine, Rohypnol (flu-
nitrazepam), methamphetamine, and lysergic acid diethy-
lamide (LSD) as “club drugs” [2], while the U.S. Office of
National Drug Control Policy described only four specific
club drugs: MDMA, GHB, ketamine, and Rohypnol [3].
Epidemiological studies have shown that factors asso-
ciated with recreational nightlife activities, such as music
preference and choice of the venue, may be considered as
relevant predictors of illegal drug use in several European
countries [4]. Similarly, in the US, Moore and Miles have
found an association between substance use and alternative
music styles in the electronic music scene [5].
It is becoming increasingly clear that the drugs used in
clubs are heterogeneous and ever-changing [6]; moreover,
during the last few years, a wide number of unregulated
natural and synthetic New Psychoactive Substances (NPS)
have made their appearance on the market [7].
NPS are drugs of abuse, either in a pure form or in
a preparation, that are not controlled by the 1961 Single
Convention on Narcotic Drugs or the 1971 Convention on
Psychotropic Substances, but that may pose a serious public
health threat. In this context, the term “new” does not
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necessarily refer to newly synthesized molecules, but mainly
to substances that have recently become available [7].Many of
these substanceswere, in fact, firstly synthesized and patented
in the 1970s or even earlier, but only recently their chemistry
or process of synthesis has been slightly modified to produce
effects similar to known illicit substances. On the basis of
the above-mentioned definition, the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA) and the
European Police Office identified the following groups of
substances, covered by the EarlyWarning System onNPS [8]:
(i) phenethylamines, which encompass a wide range of
substances that may exhibit stimulant, entactogenic,
or hallucinogenic effects;
(ii) tryptamines, which include a number of substances
that have predominantly hallucinogenic effects;
(iii) piperazines, represented, inter alia, by m-chloro-
phenylpiperazine (mCPP) and BZP, both of which are
central nervous system stimulants;
(iv) synthetic cathinones, which have stimulant effects;
the main cathinone derivatives are the semisyn-
thetic methcathinone and the synthetic compounds
mephedrone, methylone, and methylenedioxypy-
rovalerone (MDPV);
(v) synthetic cannabinoids, which are functionally similar
to Δ9-tetrahydrocannabinol (THC), the active com-
pound of cannabis.
Other substances reported by the Early Warning System
include various plant-derived and synthetic psychoactive
substances (e.g., indanes, benzodifuranyls, narcotic anal-
gesics, synthetic cocaine derivatives, ketamine and phency-
clidine derivatives), which do not strictly belong to any of the
previously mentioned drug groups. A number of medicinal
products and derivatives are also included [9].
NPS are rapidly appearing in more and more sophis-
ticated forms and often remain unregulated for a long
period [7]. EMCDDA stated that, in 2012, 280 potentially
harmful “legal highs” have been produced in Europe alone
[8]. These substances are often synthesized in underground
laboratories, simply modifying the molecular structure of
controlled drugs, hence raising concerns related to the poten-
tial presence of contaminating agents [10]. The significant
informational, promotional, and distributional capacity of
the Internet plays an important role in theNPSmarket: global
web-based marketing and distribution, distinct from illegal
street markets, have developed in the past years [9]. The
number of online shops providing customers with NPS in
European Union countries has increased from 170 in January
2010 to 314 in January 2011, and 693 in January 2012 [8]. The
Internet offers many advantages to NPS suppliers, as it allows
access to a vast number of potential users, and suppliers do
not need large upfront investments and can retain some level
of anonymity. In addition, suppliers may be able to bypass
the laws of different countries, thus making enforcement or
legal action in response to their activities very difficult. It
is also important to point out that, in many cases, sellers
fail to list ingredients, side effects, and drug interactions of
the advertised products [7]. Moreover, the Internet serves
as a repository of information for several groups of people.
Drug users can obtain information through online forums,
chat rooms, and blogs and find out about new products.They
can also share with other users their experiences and the
effects of the substances, as well as the recommended sources
and ways of delivery [10]. The possibility of purchasing
NPS from websites makes these drugs easily available to
vulnerable individuals, including children and adolescents.
These subjectsmay also be encouraged by diffuse online com-
ments/messages/videos related to NPS intake experiences.
This may be an issue of concern, if one considers that an
estimated 61% of young Europeans aged between 15 and 24
years typically quote the Internet as a potential source of
information on illicit drugs [11]. Moreover, the current legal
status of a number of NPS may arguably facilitate increasing
levels of popularity of these drugs and may affect as well the
users’ perception of risks associated with their consumption.
The idea that legality can equate with safety still remains well
grounded amongst some recreational users [12].
The limited information available suggests that NPS
spread at a global level is far from negligible, and, excluding
cannabis from the analysis, it comes close to, or even exceeds,
the spread of several controlled drugs. NPS have been
reported in many countries in recent years. What is actually
known today, however, maybe just the very tip of the iceberg,
as systematic studies on the diffusion of NPS do not exist [9],
except for single substances [13, 14].
The consumption of NPS in Italy in 2011 was estimated
to be about 1%, placing the country 27th out of 28 European
countries in the ranking of NPS use [14]. In the last years,
the Italian Department of Drug Control has promoted the
development of a concise update on the main features of
identified NPS, developing as well a series of strategic guide-
lines, objectives, and actions in order to begin constructing
a response to tackle this emerging issue [15]. Although the
Italian data are encouraging and show the effectiveness of the
countermeasures taken to deal with this new phenomenon
(e.g., to contrast NPS sale in smart shops and sex shops), the
presence of toxic products still new on the market remains
an open issue to which great attention is paid. Moreover,
while estimates on general population are essential to better
illustrate drug trends, it is also important to identify and
assess consumption prevalence among key groups and target
populations.
Aim of our study was to describe use habits and distribu-
tion of NPS and other substances in a population of young
adults. Considering that surveys undertaken in nightclubs
and other nighttime economy venues are a good source of
data in order to assess the use of recreational drugs in a
high-prevalence use population [16], we selected a sample of
young adults involved in Rome nightclub scene, investigating
substance use aswell as possible psychotropic and side effects.
2. Methods
2.1. Study Participants. A questionnaire on recreational sub-
stances misuse has been proposed between September and
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November 2013 to a population sample (18–30 years old)
in 5 nightclubs in Rome. Potential study participants were
approached by amember of the research team at the entrance
or in the smoking/chill-out area inside the clubs. The self-
administered questionnaire was collected in anonymous way
by our team of psychologists and psychiatrists, with the
support of a peer group working.
In the first part, the questionnaire included socioe-
conomic characteristics (age, gender, job status, lifestyle)
and perceived mental stress. Written informed consent was
systematically obtained for every subject, according to the
Declaration of Helsinki.
2.2. Previous Illicit Drugs Use. Study participants were
asked whether they had used, in the past, any illicit
drug among heroin (diacetylmorphine) and other opiates
(opium, morphine, codeine, heroin, fentanyl, methadone,
meperidine, L-alpha-acetylmethadol [LAAM]), cannabis
(marijuana, hashish), cocaine and derivatives (e.g., crack),
amphetamines, methamphetamine, hallucinogens (lyser-
gic acid diethylamide [LSD], mescaline, psilocybin), and
stimulatory hallucinogens (MDMA [ecstasy], phencyclidine
[PCP]). Common street names of illicit drugs, both single and
in combination (e.g., speed, speedball, spaceball), were also
listed. For illicit drugs with multiple routes of administration
(ROA), interviewees were asked to specify the ROA and
pharmaceutical form (e.g., powder, pill, dust).
Moreover, study participants were asked if they had ever
abused alcohol (according to the DSM IV-TR criteria) with
the above-mentioned illicit drugs and, in case of positive
response, they were asked to specify which drugs and the
frequency of this behavior.
2.3. Previous Use of Novel Psychoactive Substances and/or
ClubsDrugs. Study participantswere askedwhether they had
used a NPS and/or a club drug in the past. Listed substances
included synthetic cannabinoids, Gamma-hydroxybutyrate
(GHB), mephedrone, ketamine, Salvia divinorum, amyl
nitrite, and psilocybin. Common street or on-line names of
NPS (e.g., poppers, liquid ecstasy, liquid X, magic mush-
rooms) were included among the questionnaire options as
well. If the participants answered positively, they were asked
to specify if the chosen substance was a powder, a pill, or
another type of NPS.
2.4. Current Use of Psychoactive Substances and Alcohol.
Study participants were asked to indicate whether they had
used psychoactive substances in the 12 hours preceding the
questionnaire administration. If the answer was positive, they
were asked to specify if they had assumed also alcohol as well.
2.5. Data Analysis. Data are reported as means, standard
deviation, and percentages where appropriate. Statistical
comparison of the proportions of those reporting use on the
night of the survey was undertaken by Chi-square (𝜒2). SPSS
version 14.0 was used for all analyses.
Table 1
Novel psychoactive
substance/club drugs
Lifetime use (% values
of the whole sample) Absolute values
Synthetic cannabinoid 35 96
Gamma-
hydroxybutyrate
(GHB)
10.2 28
Mephedrone 18.8 51
Ketamine 18 49
Salvia divinorum 3.2 9
Amyl nitrite (poppers) 45 123
Lysergic acid
diethylamide (LSD) 24 66
Psilocybin 4 11
3. Results
3.1. Participant Characteristics. This sample was composed
of 273 subjects. Regarding the sociodemographic characteris-
tics, mean age of participants was 25.4 years, 53% were males
and 47% females, and all were residents in the municipality
of Rome. 62% of subjects lived with parents, 13% alone
and the remaining 25% with other people. With regard to
employment status, 27% declared to have a job, 46% were
students, 10% were working students, and, finally, 17% were
unemployed.
3.2. Previous Illicit Drugs Use. The prevalence of lifetime
previous illicit drugs use was 56% (n. 153), and 48% of the
subjects claimed to have consumed alcohol together with
illegal psychoactive substances at least once.
3.3. Previous Use of Novel Psychoactive Substances and/or
Clubs Drugs. Surprisingly, 78% of respondents declared a
lifetime previous use of NPS/club drugs, such as amyl
nitrite (45%), synthetic cannabinoids (35%), lysergic acid
diethylamide (LSD) (24%), mephedrone (18.8%), ketamine
(18%), Gamma-hydroxybutyrate (GHB) (10.2%), psilocybin
(4%), and Salvia divinorum (3.2%) (see Table 1).
3.4. Current Use of Psychoactive Substances and Alcohol.
At the time of the questionnaire administration, 39% of
the sample (n. 106) claimed to have assumed psychoactive
substances in the previous 12 hours. Among the most preva-
lent substances, the percentages were distributed as listed:
cocaine 89% (n. 94), cannabis 20% (n. 21), ketamine 11%
(n. 12), ecstasy 10% (n. 11), methamphetamine 5% (n. 6).
Other psychoactive substances had a prevalence of use of
less than 1% (n. 1) (see Figure 1). Overall, on the night of
the survey, cocaine had a prevalence higher than cannabis
(𝑃 < 0.001), ketamine (𝑃 < 0.001), ecstasy (𝑃 < 0.001), or
methamphetamine (𝑃 < 0.001).
Moreover, the sample showed high polydrug use frequen-
cies: among psychoactive substances consumers, the totality
(100%) claimed a concurrent alcohol consumption, and 31%
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Figure 1: Percentages of substance use within the group of current
users.
(12% of the total sample) (n. 33) claimed the assumption of
two or more illicit drugs.
4. Discussion
In the surveyed sample, a significant fraction (78%) reported
a previous lifetime history of use of one or more NPS (“legal
high”) and/or club drugs. The lifetime use of amyl nitrite
was particularly high, probably for its easy availability and its
sexual enhancing properties [17]. However, the use of newer
psychoactive substances was also very high (see Table 1 for
details). There are two main possible ways to explain this
finding: (1) a recent spread of knowledge and consumption of
NPS in the Italian youth population or (2) despite an overall
limited use, a widespread consumption in peculiar subpop-
ulations. However, notwithstanding this impressive datum,
there was no evidence of recent use (on the night of the
survey) for new psychoactive substances. On the contrary, a
very high consumption was highlighted for cocaine, followed
by cannabis and other substances commonly rubricated as
“club drugs” (ketamine, ecstasy, methamphetamine) [2, 3].
These results contrast with other studies on the recreational
drug scene in the UK, which reported a fairly significant
consumption ofmephedrone [18–20], Gamma-butyrolactone
(GBL) [21], and amyl nitrite [20]. Our results aremore similar
to reports on the nightlife scenes of US [22] and continental
Europe [23]. Cocaine is easily available and in recent years has
become cheaper than in the past [24]: these reasons can help
to explain its high prevalence of use.
Our results evidence high rates of polydrug use in the
subpopulation of nightclubs attendees. This could determine
a serious public health challenge, since pharmacological, tox-
icological, and psychopathological effects due to interactions
between these substances may be unpredictable and fatal as
well in vulnerable individuals. As previously stated, very few
pharmacological/toxicological data are available in the peer-
reviewed scientific literature, with the limited knowledge
being mostly restricted to preclinical studies. Moreover, a
polydrug usemay lead to deep neurobiochemical central ner-
vous system alterations, which may make these individuals
extremely difficult to be pharmacologically treated, even by
expert mental health professionals.
Club drugs have also an important social impact in terms
of crimes and violence [25], and they may contribute to the
global burden of diseases, together with mental disorders
and traditional illicit drugs (e.g., heroin) [26]. In 2010, illicit
drug dependence accounted for 20millionDALYs (disability-
adjusted life years), being responsible for 0,8% (0.6–1.0) of
global all-cause DALYs [27]. At present, however, the overall
dependence liability of these substances seems lower than
that of heroin and amphetamines [27].
5. Limitations
This is a pilot study with a small sample size: for definitive
conclusions it is necessary to expand the sample. However,
our sample size is comparable with that considered in other in
situ nighttime economy surveys [28]. Increasing the available
data would allow having greater statistical significance, also
in order to identify drugs complications and interactions,
to verify the indirect effects of substances on the social and
working capacity and, maybe, to evaluate the consequences
of their long-term assumption. An intrinsic limitation is that
drugs abuse in club scene appears to be jeopardized, and it
is difficult to extend the results obtained at a venue to other
venues or countries. Another limitation is that subjects may
not be aware of what drug(s) they had actually used; however
every effort was made in the attempt to be accurate (e.g., use
of substances street names, specification of formulation and
route of administration).
6. Conclusions
This survey has shown that although a significant proportion
of individuals report a lifetime use of NPS, these drugs have
little significance in the recreational drugs scene. Therefore,
to investigate the recreational drugs scene might not be the
better strategy to monitor the extent of NPS consumption
in the European Union and elsewhere. However, multicenter
large-scale studies need to be carried out. Again, it is here
suggested that better international collaboration levels are
needed to tackle the new and fast growing phenomenon of
NPS availability from the web and other channels of supply.
Regarding traditional illicit drugs, cocaine misuse is very
high in club culture, significantly higher than substances
usually identified as club drugs (MDMA, ketamine, metham-
phetamine). Moreover, health and other professionals should
be accurately informed about the trend of misuse of multiple
psychoactive substances in association with alcohol.
Further studies are needed to design better intervention
strategies in subjects with problematic recreational drugs use
within the nightclub environment.
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